Non-constant mean relative potency for antibody-dependent cellular cytotoxicity assays.
4PL
ADCC
EC50
bioassay
parallelism
similarity
Journal
Journal of biopharmaceutical statistics
ISSN: 1520-5711
Titre abrégé: J Biopharm Stat
Pays: England
ID NLM: 9200436
Informations de publication
Date de publication:
22 Sep 2024
22 Sep 2024
Historique:
medline:
22
9
2024
pubmed:
22
9
2024
entrez:
22
9
2024
Statut:
aheadofprint
Résumé
Bioassays are regulated, analytical methods used to ensure proper activity (potency) of biological products at release and during long-term storage. Potency is commonly reported on a relative basis by comparing and calibrating a concentration-response curve from the test material to that of a reference standard material. The relative potency approach depends on an assumption that the two concentration-response curves exhibit similar (equivalent) shapes, except for a potency shift. In certain circumstances, however, biological factors preclude the similarity assumption, and the traditional approach becomes unworkable. The antibody-mediated cytotoxicity assay is one example where the similarity assumption does not always hold. Other examples also arise in the fields of toxicology and pharmacology. In this work, we present a non-constant mean relative potency approach which averages the relative potency across a common range of the concentration-response curves. The proposed method captures the changing nature of the relative potency into a summary statistic that can be reported for batch calibration and quality control purposes. We provide inferential methods for this statistic and summarize the results of a simulation comparing these methods across a number of non-constant relative potency scenarios and assay conditions.
Identifiants
pubmed: 39306756
doi: 10.1080/10543406.2024.2403435
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM